CTI Life Sciences Fund

General contacts
Investor type

VC

Founded

2006

AUM

-

Location

Montreal, Quebec, Canada

Investment Ticket

-

Investment Stage

Pre-seed Seed

Region of investment

North America Europe
Investor profile last updated: 21 August, 2026

Profile

CTI Life Sciences Fund is a venture capital firm based in Montreal, Canada, founded in 2006. The firm is led by a team of experienced professionals including Ken Pastor, Laurence Rulleau, Youssef Bennani, Shermaine Tilley, and Dana Matzen, who bring extensive backgrounds in finance, pharmaceutical R&D, and corporate development. CTI Life Sciences Fund distinguishes itself as a company builder, focusing on catalyzing nascent biotech ideas into scalable companies.

The firm invests primarily in the life sciences and healthcare sectors, targeting companies at the pre-clinical and clinical development stages. CTI Life Sciences Fund operates with a dual-pronged investment strategy that emphasizes both long-term value creation and expedited exit timelines. The firm invests across North America and Europe, managing multiple funds with a focus on therapeutic and modality agnostic investments.

Notable investments by CTI Life Sciences Fund include Thryv Therapeutics - drug discovery, Kainova Therapeutics - drug discovery, Aeovian Pharmaceuticals - mTORC1 inhibitor, Glycomine - PMM2-CDG treatment, and Oligon Therapeutics - siRNA therapeutics.

Industry

Biotechnology Healthcare Services MedTech Life Sciences

Contacts

Name
Title
Email
Social Networks
avatar
Youssef Bennani Managing Partner
Managing Partner
y•••@•••
LinkedIn
avatar
Richard Meadows Managing Partner
Managing Partner
r•••@•••
LinkedIn
Upgrade to see contacts
avatar
MKxTp6XdZSgLeFEy MKxTp6XdZSgLeFEy
MKxTp6XdZSgLeFEy
[email protected]
linkedin twitter
avatar
MKxTp6XdZSgLeFEy MKxTp6XdZSgLeFEy
MKxTp6XdZSgLeFEy
[email protected]
linkedin twitter
avatar
MKxTp6XdZSgLeFEy MKxTp6XdZSgLeFEy
MKxTp6XdZSgLeFEy
[email protected]
linkedin twitter
Investment-team contacts for CTI Life Sciences Fund — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about CTI Life Sciences Fund

CTI Life Sciences Fund is a venture capital firm. It backs companies at Pre-seed and Seed.
CTI Life Sciences Fund is located in Montreal, Quebec, Canada.
CTI Life Sciences Fund was founded in 2006.
CTI Life Sciences Fund invests in companies and startups in Biotechnology, Healthcare Services, MedTech, Life Sciences.
CTI Life Sciences Fund invests in companies and startups in North America, Europe.
CTI Life Sciences Fund invests in companies and startups at Pre-seed, Seed.
CTI Life Sciences Fund can be reached through its website ctisciences.com and its LinkedIn page. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for CTI Life Sciences Fund — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query CTI Life Sciences Fund directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 21 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.